Gene expression patterns within cell lines are predictive of chemosensitivity

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Ring, Brian Z ^a   Chang, Stella ^b   Winston, L Winston ^a   Seitz, Robert S ^c   Ross, Douglas T ^a  

^a Applied Genomics Inc   (United States)

^b Juvaris BioTherapeutics Inc   (United States)

^c Applied Genomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; COMPLEMENTARY DNA; RNA;

ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA MICROARRAY; DRUG SENSITIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CORRELATION; HEALTH CARE ORGANIZATION; HUMAN; HUMAN CELL; PHARMACOGENOMICS; RNA ANALYSIS; RNA ISOLATION; RNA PROCESSING; SENSITIVITY ANALYSIS; TISSUE DISTRIBUTION; TUMOR CELL LINE; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; REPRODUCIBILITY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 40549137100     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-74     Document Type: Article

References (32)

1. Kamb A Wee S Lengauer C: Why is cancer drug discovery so difficult? Nat Rev Drug Discov 2007, 6(2):115-120. 17159925 10.1038/nrd2155
2. Kola I Landis J: Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov, 2004, 3(8):711-715. 15286737 10.1038/nrd1470
3. Shoemaker RH: The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006, 6(10):813-823. 16990858 10.1038/nrc1951
4. Scherf U Ross DT Waltham M Smith LH Lee JK Tanabe L Kohn KW Reinhold WC Myers TG Andrews DT Scudiero DA Eisen MB Sausville EA Pommier Y Botstein D Brown PO Weinstein JN: A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000, 24(3):236-244. 10700175 10.1038/ 73439
5. Weinstein JN Myers TG O'Connor PM Friend SH Fornace AJ Jr. Kohn KW Fojo T Bates SE Rubinstein LV Anderson NL Buolamwini JK van Osdol WW Monks AP Scudiero DA Sausville EA Zaharevitz DW Bunow B Viswanadhan VN Johnson GS Wittes RE Paull KD: An information-intensive approach to the molecular pharmacology of cancer. Science 1997, 275(5298):343-349. 8994024 10.1126/ science.275.5298.343
6. Ross DT Scherf U Eisen MB Perou CM Rees C Spellman P Iyer V Jeffrey SS Van de Rijn M Waltham M Pergamenschikov A Lee JC Lashkari D Shalon D Myers TG Weinstein JN Botstein D Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24(3):227-235. 10700174 10.1038/73432
7. Staunton JE Slonim DK Coller HA Tamayo P Angelo MJ Park J Scherf U Lee JK Reinhold WO Weinstein JN Mesirov JP Lander ES Golub TR: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A 2001, 98(19):10787-10792. 11553813 10.1073/pnas.191368598 58553
8. Ma Y Ding Z Qian Y Shi X Castranova V Harner EJ Guo L: Predicting cancer drug response by proteomic profiling. Clin Cancer Res 2006, 12(15):4583-4589. 16899605 10.1158/1078-0432.CCR-06-0290
9. Gyorffy B Serra V Jurchott K Abdul-Ghani R Garber M Stein U Petersen I Lage H Dietel M Schafer R: Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. Oncogene 2005, 24(51):7542-7551. 16044152 10.1038/sj.onc.1208908
10. Gyorffy B Surowiak P Kiesslich O Denkert C Schafer R Dietel M Lage H: Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer 2006, 118(7):1699-1712. 16217747 10.1002/ijc.21570
11. Lamb J Crawford ED Peck D Modell JW Blat IC Wrobel MJ Lerner J Brunet JP Subramanian A Ross KN Reich M Hieronymus H Wei G Armstrong SA Haggarty SJ Clemons PA Wei R Carr SA Lander ES Golub TR: The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313(5795):1929-1935. 17008526 10.1126/ science.1132939
12. Nakatsu N Yoshida Y Yamazaki K Nakamura T Dan S Fukui Y Yamori T: Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays. Mol Cancer Ther 2005, 4(3):399-412. 15767549
13. Gemma A Li C Sugiyama Y Matsuda K Seike Y Kosaihira S Minegishi Y Noro R Nara M Seike M Yoshimura A Shionoya A Kawakami A Ogawa N Uesaka H Kudoh S: Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database. BMC Cancer 2006, 6:174. 16813650 10.1186/1471-2407-6-174 1533844
14. Potti A Dressman HK Bild A Riedel RF Chan G Sayer R Cragun J Cottrill H Kelley MJ Petersen R Harpole D Marks J Berchuck A Ginsburg GS Febbo P Lancaster J Nevins JR: Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006, 12(11):1294-1300. 17057710 10.1038/ nm1491
15. Blower PE Yang C Fligner MA Verducci JS Yu L Richman S Weinstein JN: Pharmacogenomic analysis: Correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J 2002, 2(4):259-271. 12196914 10.1038/sj.tpj.6500116
16. Covell DG Wallqvist A Huang R Thanki N Rabow AA Lu XJ: Linking tumor cell cytotoxicity to mechanism of drug action: An integrated analysis of gene expression, small-molecule screening and structural databases. Proteins 2005, 59(3):403-433. 15778971 10.1002/prot.20392
17. Hieronymus H Lamb J Ross KN Peng XP Clement C Rodina A Nieto M Du J Stegmaier K Raj SM Maloney KN Clardy J Hahn WC Chiosis G Golub TR: Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 2006, 10(4):321-330. 17010675 10.1016/j.ccr.2006.09.005
18. Wei G Twomey D Lamb J Schlis K Agarwal J Stam RW Opferman JT Sallan SE den Boer ML Pieters R Golub TR Armstrong SA: Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 2006, 10(4):331-342. 17010674 10.1016/j.ccr.2006.09.006
19. Rickardson L Fryknas M Dhar S Lovborg H Gullbo J Rydaker M Nygren P Gustafsson MG Larsson R Isaksson A: Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. Br J Cancer 2005, 93(4):483-492. 16012520 10.1038/sj.bjc.6602699
20. Developmental Theraputics Program http://dtp.nci.nih.gov/mtargets/ download.html U95 data
21. GNF Genome Informatics Applications & Datasets http://wombat.gnf.org/ index.html U133 data
22. Skehan P Storeng R Scudiero D Monks A McMahon J Vistica D Warren JT Bokesch H Kenney S Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82(13):1107-1112. 2359136 10.1093/jnci/82.13.1107
23. Storey JD: Tibshirani R Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003, 100(16):9440-9445. 12883005 10.1073/ pnas.1530509100 170937
24. Q-Value http://faculty.washington.edu/jstorey/qvalue/Q value software
25. Wallqvist A Rabow AA Shoemaker RH Sausville EA Covell DG: Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology. Mol Cancer Ther 2002, 1(5):311-320. 12489847
26. Benjamini Y Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 1995, 57:289-300.
27. Storey JD: A direct approach to false discovery rates. J Roy Stat Soc Ser B Meth 2002, 4:479-498. 10.1111/1467-9868.00346
28. Qian HR Huang S: Comparison of false discovery rate methods in identifying genes with differential expression. Genomics 2005, 86(4):495-503. 16054333 10.1016/j.ygeno.2005.06.007
29. Yang Q Cui J Chazaro I Cupples LA Demissie S: Power and type I error rate of false discovery rate approaches in genome-wide association studies. BMC Genet 2005, 6(Suppl 1):S134. 16451593 10.1186/ 1471-2156-6-S1-S134 1866802
30. Alter O Brown PO Botstein D: Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci U S A 2000, 97(18):10101-10106. 10963673 10.1073/pnas.97.18.10101 27718
31. Wosikowski K Schuurhuis D Johnson K Paull KD Myers TG Weinstein JN Bates SE: Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns. J Natl Cancer Inst 1997, 89(20):1505-1515. 9337347 10.1093/jnci/89.20.1505
32. Wu L Smythe AM Stinson SF Mullendore LA Monks A Scudiero DA Paull KD Koutsoukos AD Rubinstein LV Boyd MR: Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 1992, 52(11):3029-3034. 1350507